Latest Articles
-
If Intuitive Surgical Stock Looks Expensive, You Need To Read This
For questions about this article or underlying research, email help@trefis.com. Intuitive Surgical (ISRG), the pioneer of robotic-assisted surgery, trades at 40.0 times its adjusted earnings over the last twelve months . This profit figure adds...
-
How Has Intuitive Surgical’s Story Changed?
For questions about this article or underlying research, email help@trefis.com. Intuitive Surgical (ISRG) stock trades at 48.3 times its earnings over the four quarters to June, against 23.0 for the S&P 500. Shareholders paying that price n...
-
How Will Intuitive Surgical Stock React To Its Upcoming Earnings?
Intuitive Surgical (NASDAQ:ISRG) is scheduled to report its earnings on Tuesday, October 20, 2026. The company has a market value of about $151.1 billion. Over the last twelve months it generated $11.0 billion in revenue and $3.5 billion in opera...
-
What Could Lift ISRG Stock?
Intuitive Surgical (ISRG) stock has lost 8.2% over the past twelve months, while the S&P 500 returned 17.1%. If you own it, you have watched the market move on without you, and if you do not, the lower price may look tempting. Either way, you...
-
Are You Overpaying For Intuitive Surgical Stock Versus Its Rivals?
Intuitive Surgical (ISRG) grows faster and earns a higher operating margin than any of the five rivals in its health care peer group. It is also the most expensive of the six when price is measured against earnings. It holds that place even after...
-
Do You Really Understand ISRG Stock’s Risk?
Look at the breakdown of Intuitive Surgical’s revenue streams —Instruments and Accessories alone generate roughly 60% of the top line on a per-procedure basis. That tight link between surgery volume and cash flow explains why investors reac...
-
Can This Number Push ISRG Stock Higher?
Intuitive Surgical (ISRG) shares fell 10.4% in the past year, while the S&P 500 returned 16.5%. Much of the market has focused on moderating U.S. procedure growth. The more telling number is 144 trade-ins in fiscal Q2 2026, up from 83 a year ...
-
How Far Could ISRG Stock Bounce From Here?
Intuitive Surgical (ISRG) stock could climb 23.9% to the April high it last fell back from, and you would risk about 5% to find out. That looks like a surgical-robot leader on sale, but the price history disagrees. Over the last two years, none o...
-
Can Intuitive Surgical Make Up For A Lower Price Per Surgery?
Intuitive Surgical (ISRG) has lost about 12% over the past year, while the S&P 500 returned about 17%. Most of the debate has been about the U.S. procedure growth slowing. The number that should worry a holder more is the money the company co...
-
Is ISRG Stock Really As Expensive As It Looks?
Intuitive Surgical (ISRG), maker of the da Vinci surgical robots, trades at about $382, some 36% below its 52-week high. Even so, you pay about 35.9 times trailing adjusted earnings . That is normalized net income with stock-based compensation ad...
-
Get Paid To Wait For ISRG Stock To Go On Sale
Intuitive Surgical (ISRG) trades near $370, about 38% below its 52-week high, after growth in its US robotic-surgery procedures slowed. Selling a put pays you now for agreeing to buy the shares much lower, and you keep the payment either way. The...
-
How Much Can ISRG Stock Still Move Against You?
Intuitive Surgical (ISRG) has handed its owners a hard year. The stock is down 25% over the trailing twelve months while the S&P 500 returned 19.3%, and it now trades about 41% below its 52-week high . After a fall like that the natural hope ...
-
ISRG Stock: The Best House On The Block Costs The Most
In the world of robotic surgery, one company is both the undisputed leader and the most expensive option, forcing investors to ask if operational excellence is worth the premium. Intuitive Surgical (ISRG), the pioneer of robotic-assisted surger...
-
Can ISRG Stock Defend Its $131B Valuation?
This is a market-broadening year for Intuitive Surgical. The company is expanding beyond its core da Vinci systems to serve a wider continuum of hospitals and surgery centers. Yet, procedure growth in the core U.S. market has moderated from rec...
-
The Hospital Bet That Reframes The Intuitive Surgical Stock Story
While investors fixate on a slowdown in current procedures, hospitals are accelerating their investment in the company’s core platform, revealing a crucial, under-appreciated strength. When a market leader’s stock is down 21% over the last...
